On July 21, Twist Bioscience rose 5.54% in regular trading, trading at $92.3 USD/share, with Turnover of $14.511 million.
Within the Biotechnology sector where Twist Bioscience belongs, the overall sector performance was mixed. Among individual stocks, Gilead Sciences down 0.8%, AbbVie up 0.92%, Amgen up 0.85%, Natera up 0.83%, Vertex Pharmaceuticals up 0.2%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)